Search research articles
Contact Us
Filters
Showing results (1-10 of 44) with videos related to
Page
of 5
Sort By:
Pathologie-Biologie
|
June 20, 2000
Apoptosis and cell cycle: distinct checkpoints with overlapping upstream control
E Jacotot, K F Ferri, G Kroemer
Journal of the National Cancer Institute
|
July 6, 2000
Mitochondrion as a novel target of anticancer chemotherapy
P Costantini, E Jacotot, D Decaudin, et al.
Journal of Animal Science
|
November 5, 2002
Effect of a preparation of Saccharomyces cerevisiae on microbial profiles and fermentation patterns in the large intestine of horses fed a high fiber or a high starch diet
B Medina, I D Girard, E Jacotot, et al.
Cell Death and Differentiation
|
April 6, 2001
Apoptosis and karyogamy in syncytia induced by the HIV-1-envelope glycoprotein complex
K F Ferri, E Jacotot, M Geuskens, et al.
Science (New York, N.Y.)
|
May 20, 1994
Response
C Callebaut, E Jacotot, B Krust, et al.
Science (New York, N.Y.)
|
December 24, 1993
T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells
C Callebaut, B Krust, E Jacotot, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1997
Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity
J Blanco, E Jacotot, C Callebaut, et al.
Experimental Cell Research
|
June 25, 1998
Increased rate of HIV-1 entry and its cytopathic effect in CD4+/CXCR4+ T cells expressing relatively high levels of CD26
C Callebaut, E Jacotot, J Blanco, et al.
Cell Death and Differentiation
|
September 30, 2006
Broad-spectrum caspase inhibitors: from myth to reality?
D Chauvier, S Ankri, C Charriaut-Marlangue, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1997
The level of CD26 determines the rate of HIV entry in a CD4+ T-cell line
C Callebaut, E Jacotot, J Blanco, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 44) with videos related to
Sort By:
Page
of 5
Pathologie-Biologie
|
June 20, 2000
Apoptosis and cell cycle: distinct checkpoints with overlapping upstream control
E Jacotot, K F Ferri, G Kroemer
Journal of the National Cancer Institute
|
July 6, 2000
Mitochondrion as a novel target of anticancer chemotherapy
P Costantini, E Jacotot, D Decaudin, et al.
Journal of Animal Science
|
November 5, 2002
Effect of a preparation of Saccharomyces cerevisiae on microbial profiles and fermentation patterns in the large intestine of horses fed a high fiber or a high starch diet
B Medina, I D Girard, E Jacotot, et al.
Cell Death and Differentiation
|
April 6, 2001
Apoptosis and karyogamy in syncytia induced by the HIV-1-envelope glycoprotein complex
K F Ferri, E Jacotot, M Geuskens, et al.
Science (New York, N.Y.)
|
May 20, 1994
Response
C Callebaut, E Jacotot, B Krust, et al.
Science (New York, N.Y.)
|
December 24, 1993
T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells
C Callebaut, B Krust, E Jacotot, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1997
Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity
J Blanco, E Jacotot, C Callebaut, et al.
Experimental Cell Research
|
June 25, 1998
Increased rate of HIV-1 entry and its cytopathic effect in CD4+/CXCR4+ T cells expressing relatively high levels of CD26
C Callebaut, E Jacotot, J Blanco, et al.
Cell Death and Differentiation
|
September 30, 2006
Broad-spectrum caspase inhibitors: from myth to reality?
D Chauvier, S Ankri, C Charriaut-Marlangue, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1997
The level of CD26 determines the rate of HIV entry in a CD4+ T-cell line
C Callebaut, E Jacotot, J Blanco, et al.
Page
of 5